Pharmacokinetics of paracetamol in the Thoroughbred horse following an oral multi-dose administration.
Bogumila PeskoJocelyn Habershon-ButcherTessa MuirBob GrayPolly TaylorSusanna FenwickPamela R HincksJames ScarthStuart W PainePublished in: Journal of veterinary pharmacology and therapeutics (2021)
Paracetamol is a widely used, non-opioid analgesic and antipyretic drug. Scientific evidence suggests that it is an effective pain treatment in equine medicine. However, there is very little published information about the pharmacokinetics of the drug in the horse. The aim of the research was to determine the pharmacokinetics of paracetamol in equine plasma and urine to inform treatment of Thoroughbred racehorses. In this multi-dose study, paracetamol was administered orally at 20 mg/kg to six Thoroughbred horses. Pre- and post-administration urine and plasma samples were collected and analysed using a quantitative liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Pharmacokinetic analysis of urine and plasma paracetamol clearance profiles was carried out, which enabled the calculation of possible screening limits (SL) that can regulate for a detection time of 120 h. Additionally, an estimation of orthocetamol concentration levels in urine was carried out to investigate any underlying relationship between the para- and ortho-isomers as both were suspected to contribute to basal levels, possibly due to environmental feed sources.
Keyphrases
- liquid chromatography tandem mass spectrometry
- chronic pain
- anti inflammatory drugs
- pain management
- neuropathic pain
- simultaneous determination
- combination therapy
- high resolution
- healthcare
- randomized controlled trial
- systematic review
- emergency department
- spinal cord
- adverse drug
- pulmonary embolism
- mass spectrometry
- solid phase extraction
- drinking water
- human health
- quantum dots